Lv51
1030 积分 2024-05-22 加入
Non-small-cell lung cancer
1个月前
已完结
Top advances of the year: Ovarian cancer
1个月前
已完结
FGFR-targeted therapeutics: clinical activity, mechanisms of resistance and new directions
1个月前
已完结
Enhancer of Zeste Homolog 2 Inhibitor SHR2554 in Relapsed or Refractory Peripheral T-cell Lymphoma: Data from the First-in-Human Phase I Study
2个月前
已完结
Senaparib as first-line maintenance therapy in advanced ovarian cancer: a randomized phase 3 trial
2个月前
已完结
Mechanisms regulating PD-L1 expression in cancers and associated opportunities for novel small-molecule therapeutics
4个月前
已完结
Glioma
4个月前
已完结
Bladder cancer
4个月前
已完结
皖公网安备34019202002308
